Literature DB >> 11035215

The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat.

B K Oktar1, F Ercan, B C Yeğen, I Alican.   

Abstract

The effect of alpha-melanocyte stimulating hormone (alpha-MSH) on colonic inflammation in the rat. In this study, we investigated the effects of alpha-MSH administration on trinitrobenzene sulfonic acid-induced colitis and the role of nitric oxide and prostaglandins in this response. alpha-MSH treatment (25 microg/rat, intraperitoneally; twice daily for 3 days) reduced the colonic macroscopic lesions compared to untreated ones in both acute and chronic colitis groups. This effect was reversed by pretreatment with the nitric oxide donor, sodium NP (4 mg/kg, intravenously) or cyclooxygenase-1 selective antagonist indomethacin (5 mg/kg, subcutaneously) in the acute group and with the cyclooxygenase-2 selective antagonist nimesulide (3 mg/kg, subcutaneously) in the chronic group. alpha-MSH had no effect on colonic wet weight and myeloperoxidase activity compared to the untreated colitis group. However, protein oxidation was markedly elevated in the alpha-MSH-treated group compared to untreated ones. Nitroprusside and indomethacin reversed the effect of alpha-MSH on macroscopic lesions in the acute groups, whereas nimesulide showed a similar effect in the chronic group. In conclusion, the results of our study show a protective role of alpha-MSH on colonic lesions which partially involves nitric oxide and prostaglandins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035215     DOI: 10.1016/s0196-9781(00)00269-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function.

Authors:  Dominik Bettenworth; Marion Buyse; Markus Böhm; Rudolf Mennigen; Isabel Czorniak; Klaus Kannengiesser; Thomas Brzoska; Thomas A Luger; Torsten Kucharzik; Wolfram Domschke; Christian Maaser; Andreas Lügering
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

2.  Effects of alpha-MSH on progesterone and nitric oxide release by cultured ovarian granulosa cells in experimental rat autoimmune oophoritis.

Authors:  S M Casalino-Matsuda; P E Durando; M E Celis
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

3.  PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

Authors:  Guillaume Dalmasso; Laetitia Charrier-Hisamuddin; Hang Thi Thu Nguyen; Yutao Yan; Shanthi Sitaraman; Didier Merlin
Journal:  Gastroenterology       Date:  2007-10-17       Impact factor: 22.682

4.  Melanin-concentrating hormone as a mediator of intestinal inflammation.

Authors:  Efi Kokkotou; Alan C Moss; Daniel Torres; Iordanes Karagiannides; Adam Cheifetz; Sumei Liu; Michael O'Brien; Eleftheria Maratos-Flier; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

5.  alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.

Authors:  Thomas A Luger; Thomas Brzoska
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

6.  Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers.

Authors:  Judit Váradi; András Harazin; Ferenc Fenyvesi; Katalin Réti-Nagy; Péter Gogolák; György Vámosi; Ildikó Bácskay; Pálma Fehér; Zoltán Ujhelyi; Gábor Vasvári; Eszter Róka; David Haines; Mária A Deli; Miklós Vecsernyés
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

7.  Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases.

Authors:  Carl Spana; Andrew W Taylor; David G Yee; Marie Makhlina; Wei Yang; John Dodd
Journal:  Front Pharmacol       Date:  2019-01-14       Impact factor: 5.810

Review 8.  Intrauterine infection/inflammation during pregnancy and offspring brain damages: possible mechanisms involved.

Authors:  Mahmoud Huleihel; Hava Golan; Mordechai Hallak
Journal:  Reprod Biol Endocrinol       Date:  2004-04-22       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.